MitoQ Modulates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction via Regulating Nrf2 Signaling
Background. Gut barrier dysfunction with alterant mucosal permeability during sepsis is a challenge problem in clinical practice. Intestinal epithelial cells (IECs) are strongly involved in mucosal oxidative stress and inflammatory response. The current study aimed at investigating the effect of Mit...
Main Authors: | Shengfeng Zhang, Qingniao Zhou, Youcheng Li, Yunli Zhang, Yinmei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/3276148 |
Similar Items
-
MitoQ Is Able to Modulate Apoptosis and Inflammation
by: Elisa Piscianz, et al.
Published: (2021-04-01) -
MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism
by: Mengyuan Cen, et al.
Published: (2021-05-01) -
MitoQ Loaded Chitosan-Hyaluronan Composite Membranes for Wound Healing
by: Tamer M. Tamer, et al.
Published: (2018-04-01) -
MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway
by: Min-yan Yang, et al.
Published: (2021-01-01) -
Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels
by: Diego Méndez, et al.
Published: (2020-08-01)